Back to Gastroenterology
Gastroenterologyv2019Evidence-Based

Mumtaz Score for Readmission in Cirrhosis

Predicts 30-day readmission risk in patients with cirrhosis following hospital discharge. This prognostic tool helps clinicians identify high-risk patients who may benefit from enhanced discharge planning, close outpatient follow-up, and preventive interventions to reduce readmission rates.

Clinical Input Parameters

years
Range: 18 — 120 years
mEq/L
Range: 100 — 160 mEq/L
g/dL
Range: 1 — 6 g/dL
days
Range: 1 — 365 days
admissions
Range: 0 — 20 admissions
points
Range: 6 — 40 points
Clinical Assessment
Awaiting Parameters
readmission risk
—%
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Mumtaz Score for Readmission in Cirrhosis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Logistic regression model incorporating age, serum sodium, albumin, length of stay, previous admissions, MELD score, hepatic encephalopathy, and ascites with specific coefficients to calculate 30-day readmission probability

Clinical Pearls & Practice Notes

  • The Mumtaz Score was developed and validated in a large administrative database of cirrhosis patients
  • This score is specifically designed for patients with decompensated cirrhosis being discharged from hospital
  • The model showed good discrimination (C-statistic 0.68-0.72) and calibration in validation studies
  • Risk factors include markers of liver disease severity, complications, and healthcare utilization patterns
  • Should be used in conjunction with clinical judgment and comprehensive discharge planning
  • May help identify patients who would benefit from transitional care interventions and close follow-up
  • Not intended to replace clinical assessment but rather to supplement risk stratification efforts

Evidence & Literature Citations

  1. Mumtaz K, Issak A, Porter K, Kelly S, Hanje J, Michaels AJ, et al. Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic Patients: A Model Based on the Administrative Database. Hepatology. 2019;70(2):630-639. doi: 10.1002/hep.30274.
  2. Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR Jr, Nguyen JH, et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol. 2011;9(3):254-9. doi: 10.1016/j.cgh.2010.10.035.
  3. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107(2):247-52. doi: 10.1038/ajg.2011.314.

Score Interpretation Ranges

Low Risk0 – 15 pts

Low 30-day readmission risk

Moderate Risk15 – 30 pts

Moderate 30-day readmission risk

High Risk30 – 50 pts

High 30-day readmission risk

Very High Risk50 – 100 pts

Very high 30-day readmission risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.